Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Black Diamond Therapeutics $231.3 million IPO
Davis Polk advised the joint book-running managers in connection with an initial public offering of 10,586,316 shares of common stock of Black Diamond Therapeutics, Inc. In addition,…
Denali Therapeutics $207 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $207 million public offering of common stock of Denali Therapeutics,…
Ciena $693 million refinancing term loan facility
Davis Polk advised a leading financial institution as sole lead arranger and bookrunner, and as administrative agent and refinancing term lender, in connection with a $693 million…
Zai Lab $300 million follow-on offering of ADSs
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of approximately $300 million of American depositary shares, representing 5,500,000 ordinary shares by the…
Applied Therapeutics $143.4 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…
Minerva R$1.235 billion equity offering
Davis Polk advised the joint bookrunners in connection with the equity offering by Minerva S.A. and VDQ Holdings S.A., a shareholder of Minerva, of common shares of Minerva for an aggregate…
Back to top